Sarafem News

Prozac, used by 40m people, does not work say scientists - Guardian Unlimited

Although the patent lapsed in 2001, fluoxetine continues to make the company money - it is now the active ingredient in Sarafem, a pill sold by Lilly for ...

http://www.guardian.co.uk/society... | Posted: Mon Feb 25 20:07:39 -0500 2008

Prozac, used by 40m people, does not work say scientists - Guardian Unlimited

Although the patent lapsed in 2001, fluoxetine continues to make the company money - it is now the active ingredient in Sarafem, a pill sold by Lilly for ...

http://www.guardian.co.uk/society... | Posted: Mon Feb 25 19:07:12 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - netPR.pl (komunikaty prasowe)

(1) Our 2008 guidance assumes generic competition for DOVONEX solution in 1Q08 and SARAFEM in 2Q08. Our 2008 guidance does not account for the impact of any ...

http://media.netpr.pl/notatka_924... | Posted: Mon Jan 28 07:40:38 -0500 2008

Indevus Pharmaceuticals Announces First Quarter Fiscal 2008 ... - CNNMoney.com

During the quarter, the Company also recognized $0.6 million from sales of DELATESTRYL(R), and $0.4 million from royalties for Sarafem. ...

http://money.cnn.com/news/newsfee... | Posted: Thu Feb 07 08:07:39 -0500 2008

Indevus Pharmaceuticals Announces First Quarter Fiscal 2008 ... - CNNMoney.com

During the quarter, the Company also recognized $0.6 million from sales of DELATESTRYL(R), and $0.4 million from royalties for Sarafem. ...

Posted: Thu Feb 07 08:07:39 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - CNNMoney.com

(1) Our 2008 guidance assumes generic competition for DOVONEX solution in 1Q08 and SARAFEM in 2Q08. Our 2008 guidance does not account for the impact of any ...

Posted: Mon Jan 28 07:37:41 -0500 2008

Warner Chilcott Sees FY08 EPS Above Wall Street View - Update [WCRX] - RTT News

The company said 2008 guidance assumes generic competition for DOVONEX solution in the first quarter of fiscal 2008 and SARAFEM in second quarter of fiscal ...

Posted: Mon Jan 28 08:41:22 -0500 2008

Warner Chilcott Sees FY08 EPS Above Wall Street View - Update [WCRX] - RTT News

The company said 2008 guidance assumes generic competition for DOVONEX solution in the first quarter of fiscal 2008 and SARAFEM in second quarter of fiscal ...

Posted: Mon Jan 28 08:41:22 -0500 2008

Warner Chilcott Announces 2008 Financial Guidance - CNNMoney.com

(1) Our 2008 guidance assumes generic competition for DOVONEX solution in 1Q08 and SARAFEM in 2Q08. Our 2008 guidance does not account for the impact of any ...

Posted: Mon Jan 28 07:37:41 -0500 2008